CDC opts for £370 million buy-in deal with Goldman subsidiary

Concern over the long-term viability of financial institutions led UK government-owned emerging market investment vehicle the CDC Group to opt for a fully collateralised buy-in when offloading its pension liabilities in a £370 million deal with Goldman Sachs’ offshoot Rothesay Life.

According to John Deed, a trustee of the CDC Group’s pension scheme, uncertainty over the global economy made the issue of securing a collateral-based deal all the more pressing: “We moved from a situation where

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

The future of life insurance

As the world constantly evolves and changes, so too does the life insurance industry, which is preparing for a multitude of challenges, particularly in three areas: interest rates, regulatory mandates and technology (software, underwriting tools and…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here